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Abstract 
Striatal dopamine (DA) has been extensively implicated in reward related processes. We 
assessed striatal DA variations and delay discounting (DD) behavior in humans by investigating 
two functional polymorphisms in genes associated with striatal DA signaling. First, the DA 
transporter (DAT), which is the primary mediator of DA clearance in the striatum; a variable 
nucleotide repeat polymorphism in the DAT gene is associated with variation in DAT 
expression, with the 9 repeat variant yielding greater DAT expression relative to longer repeats. 
Second, a single nucleotide polymorphism in the DA D2 receptor (DRD2) gene linked to 
variation in striatal DRD2 availability, with the “T” variant showing greater DRD2 availability 
relative to “C” variants.  We assessed intertemporal monetary reward choice behavior using a 
DD task and investigated whether these genetic variations could account for significant inter-
individual variance in DD behavior. Among emerging adults (ages 18-25), we observed a 
significant DAT×DRD2 interaction effect on the sensitivity of intertemporal choice to reward 
magnitude that followed an inverted U-shaped function of genetically predicted tonic striatal 
DA. Those with genetically predicted intermediate DA showed greater reward sensitivity relative 
to those with predicted high and low DA phenotypes. These results suggest that striatal DA 
signaling modulates reward-related decision-making in emerging adults.  
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The Role of Ventral Striatal Dopamine in Reward Valuation Sensitivity 
 In daily life, people often face situations where they must decide between two types of 
choices: a choice that will be beneficial immediately or almost immediately, and one that is not 
as rewarding in the present, but will have a larger reward in the future. A major example of such 
a choice is the decision whether to get a job or to attend college following high school: getting a 
job immediately reaps a beneficial salary, while attending college sacrifices such immediate 
monetary reward. However, in the future, it is likely that a college degree will increase one’s 
potential earnings, leading to a greater overall reward. Many similar choices, on smaller scales, 
are evaluated regularly as people attempt to discern whether they would rather have a lower 
value reward immediately or a larger value reward in the future (these decisions are known as 
intertemporal choices). In such situations, there are three key variables that can influence an 
individual’s choice: the relative magnitude of the delayed reward compared with the immediate 
reward, the overall magnitude of the delayed reward, and the elapsed time required before 
getting the delayed reward. In many instances, the perceived magnitude of the future reward is 
“discounted” as the time needed to obtain the reward increases, resulting in smaller perceived 
values for rewards that are expected to occur more distantly in the future.  
 Discounting future rewards, and the resulting preference for immediate rewards, is a 
universally observed characteristic across many different species, including humans (Mazur, 
1987). However, humans tend to show inter-individual variability in their valuations of 
immediate versus future rewards: some people show a greater bias towards immediate reward 
than others, while some tend to discount future rewards to a much lesser degree (Rachlin, 1989; 
Kagel et al., 1995). These differences may be quantitative measures of trait-level individual 
differences in self regulation and impulsivity (Manuck et al., 2003). Such traits have been shown 
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to be linked to individual differences in susceptibility to the development of addictive behaviors, 
such as pathological gambling and substance abuse, which provides a link between a general 
behavioral tendency (heightened immediate reward bias) and potentially debilitating disorders 
(Madden et al., 1997; Kirby et al., 1999; Alessi and Petry, 2003). Several studies have been 
conducted in order to develop a better understanding of the biological bases for individual 
differences in intertemporal choice, with the hope that this information may help determine 
biological bases for high impulsivity, and thus, increased susceptibility to certain psychological 
disorders. Such findings may eventually lead to easier identification of those at a greater risk for 
developing impulsivity-related problems, allowing for the provision of earlier interventions 
capable of helping the individuals who are affected.  
VS Activity and Reward Preference 
Multiple studies have identified one region of the brain, the ventral striatum (VS), as 
playing a major role in reward valuation, especially in the relative valuation of immediate 
compared to future rewards. In a study comparing VS activity level with interindividual 
differences in reward preferences, Hariri et al. (2006) found a positive correlation between the 
magnitude of monetary feedback-related striatal activity during a card guessing task and an 
individual’s relative preference for immediate rewards in a separate delay discounting task. This 
indicates that VS activity may be associated with the perception of temporally differentiated 
rewards. Further support for VS involvement in reward valuation comes from the finding that 
activation in the nucleus accumbens, a part of the VS, is positively correlated with the 
anticipation of increased rewards in a monetary incentive delay task (Knutson et al., 2001). 
While not providing significant information on the specific direction that the VS influences 
temporal reward preference, this finding provides additional credence to the more general 
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proposal that VS signaling is related to how rewards are valued. In an attempt to better 
understand the role of VS activity, and identify specific situations in which different regions of 
the brain impact choice, McClure et al. (2004) measured the activity in multiple parts of the brain 
as participants made preference-based choices between immediate rewards, rewards to be 
received a short time in the future, and rewards to be received even further in the future, using 
functional magnetic resonance imaging (fMRI). Relative activity levels indicated that the VS 
responded more strongly during decisions that involved an “immediate reward” as an option, 
rather than two delayed reward choices, while regions in the prefrontal cortex responded 
uniformly to all presented choices. These different response patterns indicate that the VS may 
play a specific role in the valuation of immediate rewards, rather than having a large influence on 
the valuation of “sooner” rewards in general.  Moreover, it was found that when participants 
were choosing between an immediate and future reward, those who chose the immediate reward 
showed stronger VS activity relative to prefrontal activity, while those who chose a future 
reward showed opposite activation patterns. Clearly, relative VS activity plays a major role in 
determining how temporally differentiated rewards are valued, and influences the extent to 
which future reward values are discounted. 
VS Activity and DA 
 Due to the apparent role of striatal activity in the relative valuation of immediate rewards, 
researchers have attempted to determine factors that may explain individual variability in the 
magnitude of VS signaling in response to such rewards. One factor identified as being 
significantly influential on VS signaling is variability in striatal dopamine (DA) availability. 
Using 18F-DOPA (a ligand used in the measure of DA synthesis capacity) positron emission 
tomography (PET) to measure striatal DA synthesis and BOLD fMRI to measure striatal activity, 
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Siessmeier et al. (2006) found that striatal DA synthesis capacity and activity in response to 
affective stimuli were positively correlated. Similarly, Scott et al. (2007) found, using fMRI, that 
activity in the VS increased proportionally to placebo-induced DA release (measured by PET) 
during reward anticipation during a monetary incentive delay task. In an additional fMRI study 
looking at this relationship, VS activity tended to increase following amphetamine induced DA 
release (Menon et al., 2007). These results suggest that striatal DA relates to striatal activation. 
Menon et al. (2007) suggested that this interaction stems from some yet to be understood causal 
effect of DA synthesis on VS activity. These findings were corroborated by a study that also 
compared VS activity with VS DA levels using genetic methods (Forbes et al., 2009). This study 
measured DA indirectly, via functional genetic polymorphisms previously linked to the striatal 
dopaminergic pathway(Forbes et al., 2009). Results indicated that people with genetic indicators 
of relatively increased striatal DA availability (see below) tended to have higher striatal 
activation while performing a task that involved a positive and negative feedback-associated 
monetary reward. This proposed link between genetics and VS activity carries large implications, 
as it offers the possibility of identifying a direct genetic modulator of VS activity, which, as 
already described, is associated with the valuation of reward. In order for this connection to be 
made, it is necessary that genetic influence on VS DA is sufficiently understood. 
Genetic Influences on VS DA 
 The dopaminergic circuitry is extremely complex, with a large number of interacting 
pathways influencing DA levels in various parts of the brain. These intricate pathways 
themselves are regulated by a large variety of DA regulatory genes, some of which code for 
proteins thought to be directly involved in modulating striatal DA. Two proteins known to 
influence DA signaling levels in the striatum are the DA transporter (DAT) protein and the D2 
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DA receptor (DRD2). Functional polymorphisms of the genes coding for these proteins lead to 
variations in their ability to regulate and mediate DA signaling in the brain, which may have 
impacts on cognition and behavior. 
DAT 
 The DAT regulates striatal DA levels by binding and returning extracellular DA to 
presynaptic terminals (Dreher et al., 2009). There is a common genetic variant in the 3’-
untranslated region of the DAT-1 gene, with variable number of tandem repeats (VNTR) in: a 9 
repeat (9R) version and a 10 repeat (10R) version of the gene (Vandenbergh et al., 1992). To 
date, various studies have produced inconsistent results regarding which of the variants promote 
greater DAT synthesis. Several studies have found greater DAT expression in individuals with 
the 9R VNTR (Shumay et al., 2011; van de Giessen et al., 2009), while others have found 
conflicting results, pointing towards greater DAT expression in the 10R VNTR (Heinz et al., 
2000; Mata et al., 2012). Such contradictory findings may stem from differences in participant 
composition, as some studies have looked at DAT expression in affected populations with 
ADHD, while others have looked at DAT expression in the normal population. Additionally, 
there were differences in the methods used to measure DAT expression: some studies used PET, 
while others used single-photon emission tomography (SPECT), and there were additional 
differences within these methods in terms of ligands that were used. Some resolution of this issue 
comes from a recent meta-analysis that supports the hypothesis that the 9R allele is associated 
with greater DAT production (Faraone et al., 2013). A study conducted by VanNess, Owens, and 
Kilts (2005) looked at other possible differences between DAT VNTR variants, concluding that 
binding affinity was the same for both the 9R and 10R alleles. Therefore, if the 9R DAT allele 
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leads to greater DAT expression, increased DA clearance should be observed in 9R carriers, 
resulting in less extracellular striatal DA in 9R carriers relative to 10R homozygotes.   
DRD2 
 Genetic variation in the DRD2 gene has also been implicated in the modulation of DA 
signaling in the striatum. D2 receptors are located both pre- and post-synaptically in the striatum, 
where they influence dopaminergic activity. Presynaptically, D2 receptors act as autoreceptors, 
inhibiting cell firing and DA release when DA binds to them. Post-synaptically, the D2 receptors 
also produce inhibitory affects on activity via a Gi-protein signaling cascade (Sibley et al., 1993). 
There are several identified polymorphisms in the DRD2 gene (e.g. C957T, -141C 
insertion/deletion, and the Taq1A polymorphisms), all of which are in linkage disequilibrium 
(Duan et al., 2003). For this study, we focused on the C957T SNP, based on findings that this 
SNP can impact levels of striatal DRD2 binding; striatal D2/3 receptor binding potential is 
significantly reduced among people with the C/C genotype compared to those with the T/T 
genotype (Hirvonen et al., 2004; 2005). Among several possibilities that could explain this 
finding, one potential explanation is increased D2 receptor density in the striatum associated with 
the 957T allele (Hirvonen et al., 2009). 
 Interacting Effects of DAT and DRD2 
Given the effects of the DAT and DRD2 polymorphisms discussed above on striatal DAT 
and DRD2 expression, one would expect these polymorphisms to have effects on striatal DA 
signaling, and, in turn, on behavior. Several findings exist that support this expectation for the 
DAT VNTR, with one study showing more risky behavior during a balloon analogue risk task in 
10R homozygotes, and another study showing greater striatal responsiveness during reward 
anticipation in 9R carriers (Mata et al., 2012; Dreher et al., 2009). These DAT findings illustrate 
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that DA-related genetic polymorphisms can account for individual variation in behavior. 
However, the complexity of dopaminergic signaling in the brain limits the explanatory power of 
a single genetic polymorphism in understanding behavior. 
As such, work that investigates the effects of multiple DA system regulatory components 
(e.g. DAT and DRD2) and how they interact, lends greater power to behavioral genetic studies. 
For example, a study conducted by Rokem et al. (2010) highlights the importance of looking at 
multiple mechanisms of striatal DA regulation to predict behavior. That study measured an 
involuntary attentional process called inhibition of return (IOR) in participants that were 9R 
carriers or non-9R carriers. The investigators measured IOR twice, once on bromocriptine, a 
DRD2 agonist, and once on placebo. Bromocriptine effects on IOR depended on DAT genotype: 
it reduced IOR duration in 9R carriers, but increased IOR duration in 10R homozygotes, 
illustrating that DAT genotype influences DRD2-mediated effects on human behavior and 
cognitive functioning. Further support for the complexity of striatal DA signaling comes from 
studies suggesting that DRD2 receptors directly modulate DAT reuptake activity (Meiergerd et 
al., 1993; Parsons et al., 1993; Dickinson et al., 1999; Mortensen and Amara, 2003). By this 
theory, DAT and DRD2 do not merely play two independent roles in DA transmission, but 
rather, DRD2 directly affects the capabilities of DAT in regulating the dopaminergic system, 
further emphasizing the importance of also looking at DRD2 genotype when assessing DAT 
genotype effects on behavior. Moreover, interacting effects of DAT and DRD2 may help explain 
conflicting data in the literature regarding DAT VNTR effects on DA availability. 
DA Availability and Behavior  
An additional factor to consider with regards to the observed interaction between DAT 
and DRD2 is that levels of DA availability may not linearly relate to behavior. Instead, DA may 
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impact cognition and behavior according to an inverted U-shaped function, where DA extremes 
(both low and high) influence behavior in one way, while some middle, optimal amount of DA 
may influence behavior in a different way. Mattay et al. (2003) showed that above or below 
some set critical frontal DA amount, behavioral performance in a working memory task begins 
to decline, a finding that was in line with a previously found inverted U-shaped function of  
prefrontal DA on working memory (Goldman-Rakic et al., 2000). Recent findings suggest that 
DA in the striatum may also have a similar influence on activity in this area of the brain (van 
Schouwenburg et al., 2010). In addition, a study by Bertolino et al. (2009) found that the effect 
of the DAT VNTR on brain activation during a recognition memory paradigm depended directly 
on DRD2 polymorphic context. The polymorphic combinations leading to peak activation were 
those predicted to result in an intermediate amount of DA, supporting an inverted-U shape effect 
of DA on recognition memory. In general, such a function would imply that a polymorphism of 
one gene that results in increased DA availability may have different effects depending on the 
extant DA context determined by polymorphisms of other genes affecting dopaminergic 
signaling.  
All of the above research has contributed to the major progress that has been made 
towards identifying the biological bases for individual differences in intertemporal reward 
valuation. In summary, the relevant links that have been made include those between: DAT and 
DRD2 polymorphisms and striatal DA availability (Faraone et al., 2013; Hirvonen et al., 
2004;2005; Rokem et al., 2010; Shumay et al., 2011; van de Giessen et al., 2009); DA 
availability and behavioral performance in various tasks (Bertolino et al., 2009; Goldman-Rakic 
et al., 2000; Mattay et al., 2003; van Schouwenburg et al., 2010); striatal DA availability and 
relative magnitude of VS activation levels (Forbes et al., 2009; Menon et al., 2007; Scott et al., 
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2007; Siessmeier et al., 2006); and relative VS activation levels and relative preferences for 
immediate versus future rewards (intertemporal choice tendencies) (Hariri et al, 2006; Knutson 
et al., 2001; McClure et al., 2004). It follows logically from these connections that if genetic 
variance influences DA availability, which impacts striatal activation, which itself has been 
shown to be related in some way to intertemporal choice, then through these means, variability in 
genes governing striatal DA signaling would predict substantial interindividual differences in 
reward valuation during intertemporal choice. Despite this inferred relationship, little research 
has been done to investigate this proposed link between striatal DA availability, indexed by 
functional genetic polymorphisms, and intertemporal choice tendencies.   
 In the present study, we will test whether specific genetic polymorphisms that modulate 
striatal DA availability can predict differences in immediate versus future reward valuation 
between individuals. We will use DAT and DRD2 polymorphisms as genetic markers to predict 
VS DA availability, since previous research suggests that these polymorphisms influence striatal 
DA levels. While other dopaminergic genes undoubtedly influence the function of the brain’s 
reward pathways, we have limited our focus to these, as functional consequences of these 
polymorphisms have been defined, and DAT and DRD2 are arguably the most important 
proteins specific to regulating striatal DA signaling.    
 We will evaluate differences in reward valuation by looking at individual sensitivity to 
delayed reward magnitude in an intertemporal choice task. The more sensitive a participant is to 
changes in reward value, the more rapidly their preference for an immediate over future reward 
will decline as the future reward’s subjective value increases relative to the immediate reward’s 
value. We propose that a higher sensitivity to shifts in the values of future rewards (e.g. from $2 
to $100) signifies a greater shift in the perceived value of the reward and an individual’s reward 
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sensitivity. We also propose that individual reward sensitivity can be measured across tasks by 
assessing how choice is modulated by proportional reward value increases across all choices 
(e.g. instead of a task involving $2 to $100 rewards, a new task involving $200 to $10,000 
rewards). Previous studies have suggested that participant preference for immediate over future 
reward should decline with the increase of reward magnitudes being used in the task (Green et 
al., 1997; Kirby & Marakovic, 1996). As a result, response to future reward shifts can be used as 
an index of reward sensitivity, a behavior linked to compulsive, maladaptive behaviors such as 
substance abuse, pathological gambling, and ADHD (Chen et al., 2007; Reuter et al., 2005; 
Scheres et al., 2007; Strohle et al., 2008; Wrase et al., 2007).  
 Based on previous findings linking striatal DA, VS activity, and intertemporal choice 
preferences, we hypothesized that participants with predicted “extreme” amounts of striatal DA 
availability (either low or high), based on DAT VNTR and DRD2 C957T genotypes will be less 
sensitive to changes in delayed reward value, while those with more mid-range, intermediate 
levels of VS DA will demonstrate relatively greater responsiveness to such value changes.  
Methods 
Exp 1: Striatal DA and ICR as a function of delayed reward magnitude – within task 
Participants 
Participants (n = 247) were recruited from the University of North Carolina, Chapel Hill 
(UNC) and the surrounding community. All participants were between the ages of 18 and 40 (M 
= 22.80, SD = 4.50), had at least a high school education, and were native English speakers with 
no known neurological or psychiatric diagnoses, history of substance use disorders, or recent use 
of psychoactive substances (not including caffeine, nicotine, or alcohol). All participants gave 
written informed consent, as approved by the UNC Office of Human Research Ethics, and 
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received monetary compensation for their participation. For the present study, we focused on 
data from the emerging adult participants (n = 207) within this sample (ages 18-25; M = 21.12, 
SD = 1.96). The emerging adult participants included 99 females and 108 males, with the 
following ethnic distributions: 7% Asian, 12.6% Black, 3.5% Hispanic, 71.4% White, and 5.5% 
other.  
Standard Delay Discounting Task 
 Participant impulsivity was assessed using a delay discounting task, described in detail 
previously (Mitchell et al., 2005; Altamirano et al., 2011). For the task, participants were 
positioned at a computer, and completed a task divided into eight blocks of 42 or 43 trials each. 
In each trial, participants were presented with two reward options to choose between, each 
containing a monetary amount and time value: one option, the “Later” option, had a monetary 
value of $2, $5, $10, $20, or $100 and a time value of 1 week, 2 weeks, 1 month, 3 months, or 6 
months, while the other option, the “Now” option, had a monetary value of some reduced 
proportion from the presented “Later” option (amounts differed by 5%, 10%, 15%, or 30%), and 
a time value of  “TODAY”. Each trial, participants were presented with one of four instruction 
cues immediately before the two reward choices appeared on the screen: WANT, DON’T WANT, 
SOONER, or LARGER. In each of these conditions, participants were expected to choose the 
option that best answered the question relevant to the given condition: For WANT and DON’T 
WANT trials, participants made a subjective choice about which of the two rewards they would 
prefer, or prefer not to get. For SOONER and LARGER trials, participants indicated which of the 
options was the reward that would be received sooner, or which of the options had the larger 
monetary value, respectively.  The SOONER and LARGER conditions were considered control 
conditions, with each having an objectively correct answer. The WANT condition occurred in 
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half of the trials, and the other three conditions were divided evenly among the other half of the 
trials. Participant reaction time (RT) was also recorded in each trial. Of the 207 emerging adults 
tested, eight were excluded from all analyses based on RTs in the control conditions greater than 
RTs during subjective choice trials.  
Dependent Measures 
Our main behavioral dependent measure, the impulsive choice ratio (ICR), was 
calculated as the proportion of “Now” responses made in the WANT condition with an ICR =1 
signifying a participant always choosing the “Now” option. ICR was calculated at each delay 
amount to measure how ICR varied with delayed reward magnitude.  
 To quantify reward valuation sensitivity, we fit ICR as a function of delayed reward 
value with a logarithmic function, measuring the slope and intercept of these fits using the built 
in curve-fitting function in Microsoft Excel (Mitchell et al., 2005).  
Exp 2: Striatal DA and ICR as a function of delayed reward magnitude – between task 
Participants 
 In a similar experiment following slightly different procedures, new participants (n =144) 
were recruited from UNC and the surrounding community following the same procedures and 
guidelines as those used in Experiment 1, with the exception that all recruited participants were 
between the ages of 18 and 25 (M = 21.34, SD = 1.88). The sample included 72 females and 72 
males, with ethnic distributions as follows: 4.2% Asian, 11.1% Black, 4.9% Hispanic, 74.3% 
White, and 4.9% other.  
Increased Reward Magnitude Delay Discounting Task 
 Participant impulsivity was assessed using a delay discounting task procedurally identical 
to the one described above. In this experiment, however, participants completed the delay 
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discounting task on two separate occasions. The first time they did the task, participants 
completed a task with reward values either identical to those in the task previously described (the 
standard task), or with delayed reward values 10 times or 100 times larger than those in the 
standard task: $20, $50, $100, $200, and $1,000 reward values or $200, $500, $1,000, $2,000, 
and $10,000 reward values (the 10x and 100x tasks, respectively). In their second testing session, 
participants completed the delay discounting task again, this time being assigned to the standard 
task if they had not been assigned to it the first time they did the task, or being randomly 
assigned to any of the three task variations if they had already done the standard task (all 
participants completed the standard task at least once, and some completed it twice). Participants 
were evenly and randomly assigned to the possible task combinations (standard/standard, 
standard/10x, and standard/100x), such that 48 participants were assigned to each task 
combination. Task order was counterbalanced to mitigate any practice effects.  
Comparing ICR between Tasks 
In order to quantify participant reward valuation sensitivity, we compared ICR measured 
in the standard task with that measured in the alternative (the standard-repeat, 10x, or 100x task). 
This is a within subject measure of change in ICR across two variations of the task (standard task 
ICR – second task ICR).  
Common Measures 
Genotyping 
 Participant DRD2 genotypes were determined from DNA obtained in participant saliva 
samples (DNA Genotek, Kanata, Ontario, Canada) using TaqMan technology  (Applied 
Biosystems, Foster City, Ca) as described in previous studies (Boettiger et al., 2007; Smith & 
Boettiger, 2012). DNA was genotyped by the Duke Center for Human Genetics. Genotyping 
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occurred in duplicates for some of the samples in order to ensure validity of the DNA analysis 
(Smith & Boettiger, 2012).  
 For Experiment 1, participant DRD2 genotype distribution was: 59 C/C, 86 C/T, and 53 
T/T. For Experiment 2, participant DRD2 genotype distribution was: 39 C/C, 60 C/T, and 43 
T/T. Neither experiment’s DRD2 genotype distribution differed from Hardy-Weinberg-
Equilibrium (χ2 = 3.11, df = 2, p=0.211;  χ2 = 3.414, df = 2, p=0.181). 
DAT VNTR determination was based on a PCR amplification protocol described 
previously (Anchordoguy et al., 2003). The primer sequences used in the PCR were the forward 
5’-TGT GGT GTA GGG AAC GGC CTG AG-3’, and the reverse 5’-CTT CCT GGA GGT 
CAC GGC TCA AGG-3’. Twenty µL volume reactions were used for the PCR, with each 
reaction containing: 1µL of genomic DNA (20 ng), 10% DMSO (Hybra-Max® grade; Sigma, St. 
Louis, MO), 1:8 mM MgCl2, 180 µM deoxynucleotides, with 7’-deaza-2’-deoxyGTP (Roche 
Applied Science, Indianapolis, IN) substituted for one half of the dGTP, 480 nM of both the 
forward and reverse primer (IDT, Coralville, IA), 2uL 1x PCR buffer II solution (ABI, Foster 
City, CA) and 1 unit of AmpliTaq Gold® polymerase (ABI, Foster City, CA). After DAT VNTR 
amplification, all DNA samples were read for base pair length by the Genome Analysis facility 
at UNC, Chapel Hill, using an ABI 3730xl DNA Analyzer (ABI, Foster City, CA) in order to 
determine the DAT repeat(s) they contained. Data was visualized using PeakScanner software 
(ABI, Foster City, CA), and base pair calls were made by two independent observers.  
For Experiment 1, participant DAT genotype distribution was: 17 9R/9R, 72 9R/10R, 101 
10R/10R, and 9 with either genotypes consisting of less frequent alleles (consisting of 6, 7, 8, 
and 11 repeat VNTRs) or genotypes that could not be determined. For Experiment 2, participant 
DAT genotype distribution was:13 9R/9R, 50 9R/10R, 74 10R/10R, and 7 with either genotypes 
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consisting of less frequent alleles (consisting of 6, 7, and 11 repeat VNTRs) or genotypes that 
could not be determined. In each experiment, participants with the rare/unattainable DAT 
variants were excluded from analyses looking at genetic effects on our measures of interest. 
After these exclusions, Experiment 1 used data from 190 participants for analysis, and 
Experiment 2 used data from 137 participants for analysis. 
Participants were divided into groups based on their DAT and DRD2 genotypes. With 
respect to DAT genotype, participants were split into two groups, one consisting of 9R carriers, 
and the other consisting of 10R homozygotes. 9R carriers were combined into one group to 
follow commonly used conventions for looking at this DAT polymorphism. With respect to 
DRD2 genotype, participants were split into three groups, one for C homozygotes, one for 
heterozygotes (C/T), and one for T homozygotes.  
Behavioral and Demographic Measures 
 Participants in both experiments also completed a battery of behavioral inventories 
concerning substance use, future thinking, and trait impulsivity. These inventories included the 
Barratt Impulsivity Scale (BIS; Patton et al., 1995), the Alcohol Use Disorders Identification 
Test (AUDIT; Saunders et al., 1993), the Drug Abuse Screening Test (DAST; Skinner, 1982), 
the Drug Use Screening Inventory-Revised (DUSI; Tarter, 1990), the Future Time Perspective 
Inventory (FTPI; Wallace, 1956), the Family Tree Questionnaire (FTQ; Mann et al., 1985), and 
the Rutgers Alcohol Problem Index (RAPI; Mitchell et al., 2005). For the DUSI, Domain 1 
scores were reported as % affirmative answers from Domain 1, part B. Other demographic 
information was also collected, including participant socioeconomic status (SES; Barratt, 2006), 
ethnicity, and years of education.  
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Statistical Analyses: Experiment 1 
Most demographic and behavioral differences between groups were assessed using 
between subjects 2 by 3 ANOVAs (2 DAT genotype groups by 3 DRD2 genotype groups). 
Differences in sex, ethnicity, and COMT genotype were assed with χ2 tests. Between subjects 2 
by 3 ANOVAs were also used to assess group differences in ICR delayed amount slope, overall 
ICR, and various RT measures. Additionally, post-hoc t-tests were used to further analyze 
specific group by group differences in these measures.  
Statistical Analyses: Experiment 2 
 Demographic and behavioral differences between participants in each of the task groups 
were assessed using both between groups (three task groups) one way ANOVAs and χ2 tests. A 3 
(within-subject variable: task group) by 3 (between-subject variable: DRD2 genotype group) by 
2 (between-subject variable: DAT genotype group) mixed ANOVA was used to look at 
participant group differences in ICR changes between the standard task and the alternative task 
(ICR change = standard task ICR – second task ICR (either standard, 10x, or 100x task types)). 
Within each task group, a repeated measures ANOVA of ICR by task type with DAT and DRD2 
genotype as between subject factors was used to analyze differences in participant ICR between 
task 1 and task 2. Finally, where significant DAT by DRD2 interaction effects on ICR across 
task types were found, post-hoc ANOVAs and t-tests were used to further analyze specific 
genotype group differences in these measures within a task group. 
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Results 
Exp 1: Striatal DA and ICR as a function of delayed reward magnitude – within task 
Group Characteristics/Behavioral Measures 
 The demographic characteristics and behavioral inventory results by genotype group are 
shown in Table 1. There were no significant effects of DAT, DRD2, or interaction effects of 
DAT and DRD2 for most of these characteristics, including age, years of education, and SES. 
Additionally, groups did not differ significantly in sex distribution. However, groups did differ 
significantly in ethnicity, with a smaller percentage of Caucasian participants in the DAT 10R, 
DRD2 CC group than in the other participant groups (p<.001). In addition, COMT genotype 
differed by DAT/DRD2 group (p=0.008), with a greater percentage of participants in the DAT 
9R, DRD2 TT group having the COMT Met/Met (MM) genotype. Among the behavioral 
inventories, DAT/DRD2 groups differed significantly in their scores on the AUDIT (p = 0.019), 
the AUDIT consequences subscale (p = 0.019), and the DUSI (p = 0.014). There were no 
significant differences across DAT and DRD2 genotype groups among the other behavioral 
inventories, including the BIS (p=0.636), a self-report measure of trait impulsivity. 
Delay Discounting Task ICR Measures 
Various task performance measures for each of the genotype groups are reported in Table 
2. There were no significant main effects of either DAT or DRD2 on ICR delayed amount slope 
(DAT: F(2,184)=0.181, p=0.671; DRD2: F(2,184)=0.125, p=0.883). However, there was a 
significant DAT by DRD2 interaction effect on ICR delayed amount slope (F(2,184)=9.888, 
p<.001). These results remained significant even after controlling for group differences in 
ethnicity, AUDIT scores, DUSI scores, and COMT (F(2,179) = 10.340, p<.001). Within the DAT 
9R carriers, the DRD2 TT group (lower DRD2 receptor expression) had a significantly flatter 
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ICR delayed amount slope compared with the intermediate expression DRD2 CT group (t(62)= -
2.478, p=0.016) and the higher expression DRD2 CC group (t(49)=-3.306, p=0.002). Within the 
DAT 10R homozygotes, there was a trend towards the DRD2 TT group having a significantly 
steeper ICR delay amount slope compared with the DRD2 CT group (t(69)=1.743, p=0.086); The 
DRD2 TT group did have a significantly steeper slope than the DRD2 CC group (t(44.8)=2.995, 
p=0.004). When looking at our hypothesized intermediate DA groups (DAT 9R, DRD2 CC and 
DAT 10R, DRD2 TT), there was no significant difference in ICR delayed amount slope 
(t(49)=0.031, p=0.976). In fact, average slope for each of these groups were nearly identical 
(9R/CC M= -0.275±0.160; 10R/TT M= -0.273±0.184). These ICR by delayed amount slope 
results can be seen in Figure 1. While DAT and DRD2 genotypes interacted to influence this 
slope, they did not have an interaction effect on overall ICR collapsed across all delayed reward 
magnitudes, even after controlling for group differences in ethnicity, AUDIT, DUSI, and COMT 
(F(2,179)=0.064, p=0.938).  
Delay Discounting Task Reaction Times  
We found a significant DAT by DRD2 interaction effect on participant RT (even after 
controlling ethnicity, AUDIT, DUSI, and COMT). This effect was seen on WANT – CONTROL 
RT, a measure of how much longer it takes participants to make a subjective WANT choice 
compared to objective decisions about the rewards (SOONER and LARGER evaluations) 
(F(2,179)=5.813, p = .004). Within the DAT 9R carriers, the DRD2 TT group had a significantly 
faster RT compared with the DRD2 CT group (t(62)= 2.015, p=0.048) and the DRD2 CC group 
(t(49)=2.846, p=0.006). Within the DAT 10R homozygotes, the DRD2 TT group had a 
significantly slower RT than the DRD2 CC group (t(54)= -2.699, p=0.009). Similar to the ICR 
delay amount slope comparisons for our hypothesized intermediate DA groups, average WANT – 
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CONTROL reaction times were similar between the groups, with no significant difference (t(49)=-
0.325, p=0.747).  
Showing similar trends as the WANT – CONTROL RT measure, there was a significant 
DAT by DRD2 interaction effect on DON’T WANT – CONTROL RT, (F(2,179)=6.957, p = 0.001), 
an additional measure comparing the objective decisions to an alternative subjective condition, 
even after controlling for group differences. Comparisons between individual genotype groups 
showed qualitatively similar results to the differences found between groups for WANT – 
CONTROL RTs. Both the WANT and DON’T WANT versus CONTROL RT results can be seen in 
Figures 2. 
Once again, there were no significant main effects of DAT or DRD2 alone on either of 
these RT measures. There were also no significant DAT by DRD2 interaction effects on RT in 
either the SOONER or LARGER objective, control conditions (SOONER RT: F(2,179)=1.745, 
p=0..178; LARGER RT: F(2,179) =2.230, p=0.110). There was a significant interaction effect of 
DAT by DRD2 on WANT RT (F(2, 179) = 5.921, p = 0.003), with groups showing a qualitatively 
similar pattern of RT differences as seen using the WANT – CONTROL RT measure. Each of 
these measures were made controlling for ethnicity, AUDIT, DUSI, and COMT. 
Exp 2: Striatal DA and ICR as a function of delayed reward magnitude – between tasks 
Group Characteristics/Behavioral Measures 
 In Experiment 2, three different task administration groups were evaluated: standard-
standard, standard-10x, and standard-100x (order counter-balanced). The demographic 
characteristics and behavioral inventory results for participants in each of these groups are shown 
in Table 3. Significant differences between groups were found for BIS Planning subscale scores 
(p=0.032), with participants in the standard-100x task group having reduced scores compared to 
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the other groups, and for FTPI mean extension scores (p=0.044), with participants in the 
standard-10x task group having reduced scores compared to the other two groups. Other 
demographic characteristics and behavioral measures did not differ significantly between 
participants in each of the three task groups. 
Delay Discounting ICR Changes across Task Groups 
As a DAT by DRD2 interaction effect on ICR delay amount slope was found in 
Experiment 1 (ICR changed as a function of delay reward value within the standard delay 
discounting task differentially based on DAT/DRD2 genotype), we looked to see whether 
participant delay discounting behavior (as indexed by ICR) was modulated by interactions 
between DAT and DRD2 as the magnitude of reward values changed across variations in our 
discounting task. As expected, task type by itself had a main effect on change in ICR 
(F(2,117)=25.799,  p<.001), even after controlling for task group differences in BIS Planning and 
FTPI mean extension scores, with greater changes in reward values (e.g. standard task ICR - 
100x task ICR) resulting in the largest change in participant ICR between tasks. As mentioned, 
this effect has been shown in previous findings relating increasing reward magnitude to reduced 
discounting of delayed rewards (Green et al., 1997; Kirby & Marakovic, 1996).There was also a  
significant task group by DAT by DRD2 interaction effect on ICR change (F(4, 119)=3.174, 
p=0.016). This effect was still significant after controlling for task group differences in the BIS 
Planning subscale and FTPI mean extension (F(4,117)=3.439, p=0.011).  Based on this task group 
by DAT by DRD2 interaction, further DAT by DRD2 effects were investigated for each of the 
three task groups independently.  
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Delay Discounting ICR Changes by Task Group 
For the standard-standard task group (identical reward values used for both tasks), there 
was no significant difference in participant ICR between task 1 (standard) and task 2 (standard) 
(F(1,41)=0.712, p=0.404). Further, there was no significant task type by DAT by DRD2 
interaction effect on ICR change across separate administrations of the standard discounting task 
(F(2,41)=1.258, p=0.295). 
For the standard-10x task group (standard reward values used  in one task, 10x reward 
values used in the other task), there was a significant difference in participant ICR between task 
1 (standard) and task 2 (10x) (F(1,37)=44.744, p<.001). This finding indicates participants 
recorded lower ICR scores during the 10x reward task compared with their recorded ICR from 
the task with the smaller, standard reward values, which we hypothesized would be the case. 
However, as seen in the standard-standard task group, there was no significant task type by DAT 
by DRD2 interaction effect on ICR change between tasks (F(2,37)=1.026, p=0.368). 
For the standard-100x task group (standard reward values used in one task, 100x reward 
values used in the other task), there was a significant difference in participant ICR between task 
1 (standard) and task 2 (100x) (F(1,41)=53.121, p<.001), demonstrating that participants in this 
treatment group showed a decline in ICR in the task with the 100x reward values compared with 
ICR in the task with the standard reward values. Differing from the other task groups, the 100x 
task group showed a significant task type by DAT by DRD2 interaction effect on ICR 
(F(2,41)=3.911, p=0.028), suggesting that the degree to which ICR declined from the standard to 
the 100x task varied as a function of DAT and DRD2 genotype. We further investigated how the 
ICR change between the standard and 100x task (standard task ICR minus 100x ICR) differed 
between DAT/DRD2 genotype groups. Within the DAT 9R carriers, the DRD2 TT group had a 
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significantly smaller ICR change compared with the DRD2 CC group (t(10)= 2.252, p=0.048). 
Within the DAT 10R homozygotes, there was a trend towards the DRD2 TT group having a 
significantly greater ICR change compared with both the DRD2 CT group (t(17)= -1.89, p=0.076) 
and the DRD2 CC group (t(13)= -1.988, p=0.068). While the DRD2 TT group did not differ 
significantly from either the DRD2 CT or CC group, when these two C carrier groups were 
collapsed together, a significant difference was found between the TT group and the combined C 
carrier group (t(21)= -2.377, p=0.027), with the TT group having a greater ICR change.   When 
looking at our hypothesized intermediate DA groups, there was no significant difference in ICR 
change (t(13)=0.158, p=0.877). The average ICR change between the groups was very similar 
(9R/CC M= 0.369±0.112; 10R/TT M= 0.388±0.230). The standard-100x task group ICR change 
results can be seen in Figure 3.  
Discussion 
 The purpose of this study was to analyze whether variations in both the DAT and DRD2 
striatal DA related genes had any predictive value on responsiveness to change in reward value, 
and if so, to attempt to more clearly discern this relationship between genetics, levels of striatal 
DA, and reward sensitivity. To accomplish this goal, we used two separate experiments, each 
with its own set of participants and operational measure of reward sensitivity, with the 
expectation that similar results in each experiment would provide stronger support for findings of 
the study. 
 In order to better understand the overall meaning/significance of differences in reward 
sensitivity between our six genotype groups, it was important to understand how the groups 
related to one another in the context of hypothesized striatal DA availability. A recent meta-
analysis suggested that the DAT 9R VNTR leads to greater DAT expression in the striatum than 
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the 10R VNTR (Faraone et al., 2013), and previous findings have linked the DRD2 957T allele 
to greater DA binding potential than the 957C allele (Hirvonen et al., 2004; 2005), interpreted as 
greater DRD2 expression and lower striatal DA tone in the “T” allele. These studies provided 
support for the placement of the six genotype groups on a continuum of hypothesized, 
genetically determined striatal DA availability. Based on these findings, we ranked the six 
genotype groups, from lowest striatal DA availability to highest as: DAT 9R, DRD2 TT < DAT 
9R, DRD2 CT < DAT 9R, DRD2 CC < DAT 10R, DRD2 TT < DAT 10R, DRD2 CT < DAT 
10R, DRD2 CC. 
Exp 1: Striatal DA and ICR as a function of delayed reward magnitude – within task 
 Comparing the ICR delay amount slopes of the different genotype groups revealed a 
significant DAT by DRD2 interaction effect on slope steepness. This finding, along with the 
absence of main effect of either of the genes alone on slope, supports the idea that DAT and 
DRD2 likely interact, whether directly or indirectly, in their influence on reward-related neural 
pathways in the brain. Comparing the slope values of each of the six groups, going from the 
group with the least hypothesized DA availability (DAT 9R, DRD2 TT) to the group with the 
greatest hypothesized DA availability (DAT 10R, DRD2 CC) revealed an inverted U-shaped 
function of DA availability on slope, where the two groups with intermediate amounts of striatal 
DA had the steepest average slope, while groups with extreme amounts of DA availability (low 
or high) had the flattest slopes. In terms of reward sensitivity, this suggests that the intermediate 
DA groups were more responsive to changes in reward value than groups with more extreme 
levels of DA.  
 Interestingly, when groups were compared for differences in how long it took to make 
subjective decisions in the discounting task (reaction time measures), a similar pattern was found 
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in differences between the genetic groups. The groups with intermediate DA levels took longer, 
on average, to make subjective choices (WANT, DON’T WANT) than the extreme DA groups did. 
This pattern was not observed, however, for the time it took to make objective, CONTROL 
decisions, suggesting that DAT and DRD2 genetic differences, and their resulting impacts on 
striatal DA and neural pathways, may be specifically implicated in deliberation and responding 
to rewards, rather than more general differences in global cognitive response speed or attention. 
It should also be noted that those who were more reward sensitive tended to take longer, on 
average, deliberating on their reward preference than those who were less reward sensitive. 
Given that those individuals who were most reward sensitive were also the most deliberative in 
making their subjective responses, we can rule out the possibility that, in this dataset, reward 
sensitivity is being driven by impulsivity in reward-related responding. If that were the case, we 
would have expected to see the intermediate striatal DA groups as relatively quicker at making a 
subjective response than those on the extreme ends of striatal DA. This effect was not observed. 
In fact, we observed no differences in trait impulsivity (BIS scores) between groups or cognitive 
impulsivity as measured by overall ICR. Thus, our striatal DA related findings do not appear to 
be driven by response, trait, or cognitive impulsivity differences across groups.  
Exp 2: Striatal DA and ICR as a function of delayed reward magnitude – between task 
 In Experiment 2, our measure of reward sensitivity was the change in ICR from the 
standard version of our discounting task to one with increased reward values (10x, 100x), shown 
previously to modulate choice behavior (Green et al., 1997). As expected, we observed a main 
effect of task group on ICR change, providing support for the idea that discounting decreases 
with increasing reward magnitude from the standard-standard to standard-10x task groups, and 
from the standard-10x to the standard-100x task groups. 
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Looking at how DAT, DRD2, and task group in the delayed discounting task variations 
(standard-standard, standard-10x, or standard-100x) impacted change in ICR between two task 
types (standard ICR – alternate ICR), we found that DAT and DRD2 interacted with task group 
to have a significant effect on ICR change. Individuals with intermediate levels of hypothesized 
striatal DA tone appeared to be most sensitive to the effects of increasing reward value across 
task types.  
Because of our specific interest in the relationship between DAT and DRD2 
polymorphisms on reward sensitivity, we looked at each task group on its own to see if any of 
the specific task conditions were demonstrative of a DAT by DRD2 influence on reward 
sensitivity. No interaction effect of DAT or DRD2 was seen on ICR change in either the 
standard-standard task group (which was to be expected, since there was no consistent change 
between the identical tasks) or the standard-10x task group. However, a significant interaction 
effect of DAT and DRD2 on ICR change in the standard-100x task group showed a pattern of 
reward sensitivity for the different genotype groups similar to that seen in Experiment 1. In this 
case, the more intermediate DA genotype groups had the greatest decrease in ICR going from the 
standard task to the 100x task, while the groups with more extreme DA levels had the least 
change in ICR. Relating ICR change to reward sensitivity, Experiment 2, like Experiment 1, 
suggests that proposed intermediate striatal DA groups were more sensitive to changes in reward 
value than the more extreme DA groups, as demonstrated by their greater change in “Now” 
choice selection (ICR) as a function of reward value.  
Overall Conclusions  
 In each of the two experiments outlined above, results indicated an inverted U-shaped 
function of genetically inferred striatal DA on two distinct measures of reward sensitivity: ICR 
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delay amount slope and ICR change across increasing reward value task types. In each of these 
relationships, the more intermediate DA groups showed greater sensitivity to changes in reward 
value than did DA groups that had either less or more expected DA. The fact that both of our 
experiments, with their independent participant sets and reward sensitivity paradigms, 
corroborate in the effects of striatal DA on reward sensitivity provides strength to our findings. 
In support of the initial hypothesis that participants with more extreme amounts of striatal DA 
availability (those in the DAT 9R carriers, DRD2 TT, and DAT 10R homozyogtes, DRD2 CC 
genotype groups) would be the least sensitive to changes in reward value, while those more 
average/intermediate levels of striatal DA would be more sensitive to such changes, these results 
point towards the existence of some “optimal” intermediate level of DA relating to enhanced 
reward valuation. In contrast, deviation from this optimal DA level, whether through increased or 
decreased DA levels, may potentially hinder said processing. Overall, this study indicates that 
there is a distinct inverted U-shaped relationship between genetically predicted striatal DA tone 
and reward sensitivity, providing an indication of how DAT and DRD2 genotypes may have an 
interacting influence on reward processing.  
Inverted U-Shaped DA-Behavioral Functioning Interactions 
 The inverted U-shaped functioning of inferred striatal DA on reward sensitivity that is 
suggested by this study is not a completely unique concept, and falls in line with previous 
literature suggesting other inverted U-shaped influences of DA on cognitive processes. For one, 
previous studies on working memory and prefrontal cortex function have shown inverted U-
shaped relationships between frontal DA and working memory/cognitive functioning (Cools & 
D’Esposito, 2011; Cools & Robbins, 2004). While our study was looking at striatal, rather than 
frontal DA, it is not a large stretch to predict similar DA effects on the striatum, as frontostriatal 
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circuits are critical in reward related behaviors (Haber & Knutson, 2010). Additionally, Bertolino 
et al. (2009), examining DAT and DRD2 polymorphic differences, found preliminary evidence 
suggesting that these genes, through their effects on DA availability, interact to affect neural 
activity in both the prefrontal cortex and striatum, and the structure of gray matter in the caudate 
(part of the striatum). Similar to our findings, these effects were shown to take on a variety of 
inverted U-shaped relationships, providing further support to the idea that DAT and DRD2 may 
have interactive effects on a variety of cognitive, behavioral, and neurological measures. 
 While each of the above studies provides support for the inverted U-shaped DA 
influences in various parts of the brain in relation to cognitive processes such as working 
memory, neither study focused on how striatal DA influences reward-related behavior. The 
present study extends these results, providing evidence of an effect of striatal DA on behavioral 
functioning, specifically related to reward valuation. The existence of similar patterns of 
dopaminergic effect in both frontal and striatal regions of the brain is not surprising, and may be 
explained by the importance of frontal-striatal interactions through various neural loops in the 
brain (Haber & Knutson, 2010). These frontal-striatal loops are thought to be important in 
translating reward-related stimuli into action, and as a result, are thought to play major roles in 
reward-related learning. Because of the interconnectedness of frontal and striatal regions of the 
brain, it is reasonable to believe that regulatory effects of DA tone on frontal-related functioning 
may be similar to effects on striatal-related functioning. In summary, the present study’s findings 
of a striatal DA inverted U-shaped function on reward sensitivity fit well with conclusions made 
by previous literature regarding DA’s influence on the brain, while extending these findings to 
the previously understudied striatal DA influence on reward-related behaviors. 
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DAT and DRD2 Interactions 
 The DAT by DRD2 genetic interactions and resulting inverted U-shaped influence on 
reward sensitivity shown by this study provide evidence that DAT genotype alone, and resulting 
DAT expression levels, are not sufficient to predict striatal DA-related behaviors. DAT 
expression is high in the striatum, making it the major DA regulator and tone setter in this region 
(Cools et al., 2008). Our findings demonstrate that the DRD2 polymorphic context that a 
particular DAT polymorphism operates in can modulate reward-related behavior, suggesting that 
DRD2 expression also has a major influence on how the striatum processes reward-related 
information.  
 Despite the unquestionable importance of DRD2 on striatal DA, the gene has not been 
the subject of much study, with only the Hirvonen studies (2004, 2009) looking extensively at 
the influence of the C957T polymorphism on striatal expression. As a result, mechanisms of 
DRD2 activity and influence on DA in the brain are unclear, and the global impact of the C957T 
SNP, beyond its association with receptor availability (Hirvonen et al., 2004) is not well 
understood. In fact, Hirvonen et al. (2009) suggests that the SNP may have different 
relationships to extrastriatal DA than it does to striatal DA. Nevertheless, our data suggests that, 
regardless of mechanism, DRD2 seems to have an influential role on mediating the effects of 
variations in the DAT gene on reward sensitivity, stressing the importance of using a multi-
genetic model when analyzing the polymorphic effects of DAT on striatal DA and related 
behaviors.  
 The effect of the DRD2 interaction with DAT on striatal DA may be important to 
consider with regards to the conflicting results of previous studies looking at the effects of the 
DAT 9R and 10R VNTRs on levels of striatal DAT expression (Costa et al., 2011; Faraone et al., 
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2013). Depending on the DRD2 genotype composition of 9R and 10R DAT participant groups, 
we hypothesize that the experimentally determined effects of 9R and 10R DAT VNTRs on 
striatal DA may vary. As an example in the context of the present study, an investigation of the 
effect of DAT on reward sensitivity would have yielded different results based on whether there 
were more DRD2 CC or TT participants in either one of the DAT groups. For this reason, future 
studies investigating DAT expression in the striatum should take participant DRD2 genotype into 
account when analyzing the effects of different DAT genotypes on behaviors thought to be 
subserved by the striatum.  
Implications  
 A more complete understanding of the manner in which striatal DA influences the 
activity of reward related regions of the brain may have the potential to assist in the treatment of 
individuals with various reward responsivity-related disorders. As mentioned by Andrews et al. 
(2011), a number of pathological conditions have been shown to be related to the reduced 
activation of various reward-related regions of the brain, as measured by fMRI during a 
monetary incentive delay task. Included among these conditions are substance abuse, 
pathological gambling, and ADHD, all potentially debilitating problems if not properly treated. 
Additionally, Andrews et al. (2011) found this same pattern of reduced activity in the nucleus 
accumbens of at-risk individuals with a family history of alcoholism. Provided a link between 
neural activation and reward sensitivity, the present study’s findings describing how DAT, 
DRD2, and DA relate to reward sensitivity may play an important role in determining the proper 
treatment to fix the underlying neurological conditions possibly contributing to such disorders. 
 As this study shows, reward sensitivity is related to striatal DA availability on an inverted 
U-shaped curve. This suggests that for different people with the same disorder and reduced 
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reward sensitivity, underlying dopaminergic contributors might vary significantly: for some 
people, reduced sensitivity may be due to having less than optimal amounts of DA in the 
striatum, while for others, it may be due to having too much DA. For these very different 
populations, divergent treatments would be necessary for a return to optimal levels of DA. If 
useful pharmacological treatments were to become available for these conditions, an 
understanding of this curve, and an individual’s baseline level of DA, would be necessary in 
order to determine whether the best treatment for a given case of the same condition would be a 
DA agonist, to “increase” DA signaling, or a DA antagonist, to “decrease” DA signaling.  
 Another important link that these findings provide is the direct connection between DAT 
and DRD2 genotype and predicted reward sensitivity. This relationship may provide support for 
the use of a simple and effective genetically-based screening method for identifying individuals 
who belong to DAT and DRD2 groups that may potentially put them at risk for having the 
reduced reward responsivity that may be a risk factor for certain disorders. By providing an easy 
method for screening individuals for DA-related risk factors, as opposed to the more difficult 
task of testing DA levels directly through PET, potentially problematic cases may be identified 
before a more serious disorder presents itself, increasing the chances of helping individuals 
whose striatal DA tone could increase their risk for developing particular pathologies. 
Future Directions 
 While the findings of this study help to clarify the role of DAT and DRD2 genetics and 
striatal DA on reward sensitivity, further research is needed to clarify the mechanisms by which 
these polymorphisms and DA influence behavior.  
 To begin, in this study, predictions were made based on previous literature about how 
DAT and DRD2 polymorphisms influence DA related signaling in the striatum. While the ideas 
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used were well substantiated, more direct study of how DAT and DRD2 polymorphisms 
functionally interact to influence DAT and DRD2 receptor expression and availability may 
provide more concrete support for the relationships between the two polymorphisms studied 
here. A PET study could be completed to assess DA receptor levels in the different genotype 
groups to determine whether receptor density correlates/tracks with DAT and DRD2 genetics as 
expected. Findings in such a study would be important in determining whether DAT and DRD2 
polymorphic influences on receptor expression and striatal DA availability are actually what is 
driving differences in reward sensitivity, as this study suggests.  
 Additionally, it would be useful to be able to generalize the findings of the DAT and 
DRD2 effects on reward sensitivity to other reward related tasks. Genetic neuroimaging studies 
using other tasks, such as the commonly used monetary incentive delay task (Knutson et al., 
2001), to look at reward sensitivity and other reward-related behaviors would provide support to 
the idea that DAT and DRD2 may have a relatively global influence on reward-related 
behaviors. Similarly, it would be of interest to determine whether these results generalize to other 
DRD2 variants, such as the -141C insertion/deletion and TAQ 1A polymorphisms, DRD2 SNPS 
that have been widely studied in other behavioral, cognitive, and reward-related activities 
(Forbes et al., 2009). It is believed that this generalization should be possible, and similar 
patterns should be found, using either of these polymorphisms rather than the C957T SNP, as 
Duan et al. (2003) has suggested that all of these DRD2 variants are in linkage disequilibrium. 
Overall, the more our results can be extended to previous findings, the more useful they will be 
in application to future studies and the further unraveling of genetic and dopaminergic influence 
on reward related behavior.  
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Finally, it should be remembered that the dopaminergic system of the brain is extremely 
complex, and is influenced by far more factors than DAT and DRD2 expression alone. As a 
result, as research on reward sensitivity expands, the influence of a variety of other dopaminergic 
variables should be accounted for. The genes studied here are thought to primarily reflect tonic, 
global DA, but it is known that both tonic and phasic DA (DA levels in response to some 
stimulus) are important in influencing brain activity, and perhaps how the brain responds to 
rewards (Goto et al., 2007). These two types of dopaminergic signaling mechanisms may 
potentially interact to influence reward related behavior. As one example, a lower level of tonic 
DA could potentially lead to a more salient phasic response, while a higher level of tonic DA 
may make a similar phasic response stand out less from the baseline DA level. In each condition, 
the tonic DA context impacts the relative effects of phasic DA release and signaling in response 
to a stimulus. Also contributing to the complexity of the DA system are numerous other genes 
potentially interacting with DAT and DRD2 to influence dopaminergic pathways in the brain. 
One such gene, COMT, is thought to play a major role in modulating frontal DA, both tonic and 
phasic (Bilder et al., 2004; Dreher et al., 2009; Wu et al., 2012). Despite the fact that COMT is 
thought to be more involved in modulating frontal DA, it may also have downstream effects on 
striatal DA due to previously mentioned frontal-striatal loops involved in reward behavior. 
Demonstrating the potential importance of a variety of additional genes, Nikolova et al. (2011) 
created a DA profile score based on multiple genetic polymorphisms, including DAT and DRD2, 
but also COMT and DRD4. This score was found to have predictive value on reward-related VS 
reactivity, despite the lack of predictive power of any of the genes alone. In sum, the 
dopaminergic system is affected by many variables, all of which should eventually be considered 
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in future studies in order to gain the fullest understanding of the role of striatal and frontal DA in 
reward related behaviors.   
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Table 1. Experiment 1: Demographic data by genotype groups (ages 18-25) 
  
DRD2  
C/C 
DAT 10R  
(n = 30) 
 
DRD2  
C/T 
DAT 10R  
(n = 45) 
 
DRD2  
T/T 
DAT 10R  
(n = 26) 
 
DRD2 
C/C 
DAT 9R 
(n = 25) 
 
DRD2  
C/T 
DAT 9R 
(n = 38) 
 
DRD2  
T/T 
DAT 9R 
(n = 26) 
 
 
 
F(2, 184) (p) 
 
Demographics       
Age (yrs) 21.2 ± 2.1 21.4 ± 1.9 20.8 ± 1.7 21.2 ± 2.0 20.8 ± 1.9 21.2 ± 2.0 1.034 (0.357) 
Edu (yrs) 14.8 ± 1.5 14.8 ± 1.4 14.6 ± 1.6 14.7 ± 1.8 14.8 ± 2.0 14.7 ± 1.5 0.070 (0.932)a 
Subject SES 50.4 ± 9.4 49.0 ± 9.7 52.4 ± 8.1 49.7 ± 9.2 52.7 ± 6.2 49.3 ± 8.7 2.689 (.071) 
Sex  
(% female) 
50.0 44.4 50.0 68.0 47.4 42.3 (0.480)†# 
Ethnicity  
(% white) 
16.7 71.1 92.3 72.0 94.7 88.5 (<.001)†# 
COMT (% MM) 13.3 28.9 23.1 32.0 26.3 46.2 (.008)†$ 
Psychometrics       
AUDIT 8.2 ± 5.5 10.3 ± 6.9 8.5 ± 6.0 8.3 ± 5.6 6.6 ± 4.6 10.3 ± 5.3 4.058 (0.019)b 
Consump. 4.7 ± 3.0 5.6 ± 2.5 5.1 ± 2.4 4.7 ± 2.0 4.4 ± 2.3 5.7 ± 2.3 2.247 (0.109)c 
Dependence 1.1 ± 1.2 1.4 ± 1.7 1.0 ± 1.5 0.9 ± 1.2 0.6 ± 1.0 1.0 ± 1.1 1.817 (0.166)c 
Conseq. 2.3 ± 2.3 3.4 ± 3.3 2.8 ± 2.9 2.8 ± 3.1 1.6 ± 1.9 3.6 ± 2.9 4.042 (0.019)c 
BISCUM 59.4 ± 10.2 59.5 ± 10.3 59.6 ± 9.7 62.5 ± 9.1 59.8 ± 8.6 59.6 ± 9.3 0.454 (0.636)b 
BISAttn 15.3 ± 3.8 15.5 ± 3.8 15.8 ± 3.4 16.6 ± 2.7 16.2 ± 3.4 16.0 ± 3.2 0.357 (0.700)b 
BISMotor 21.9 ± 3.2 21.7 ± 4.2 22.5 ± 3.7 22.5 ± 3.7 22.2 ± 3.7 21.8 ± 3.8 0.426 (0.654)b 
BISPlanning 22.2 ± 4.9 22.2 ± 4.5 21.4 ± 4.7 23.4 ± 4.9 21.3 ± 4.1 21.8 ± 5.1 0.853 (0.428)b 
DAST 2.1 ± 2.6 2.3 ± 2.4 2.1 ± 2.4 1.9 ± 2.4 1.7 ± 2.0 2.5 ± 2.7 0.653 (0.522) 
DUSI 0.25 ± 0.21 0.32 ± 0.21 0.26 ± 0.17 0.30 ± 0.21 0.23 ± 0.17 0.34 ± 0.18 4.382 (0.014) 
FTPI Mean 7.4 ± 5.2 7.7 ± 6.4 7.9 ± 4.9 8.7 ± 6.5 8.4 ± 5.2 6.8 ± 5.8 0.619 (0.540) 
RAPI 8.6 ± 8.5 10.7 ± 10.3 7.7 ± 6.7 8.1 ± 7.1 6.1 ± 6.7 9.0 ± 5.3 2.481 (0.086) 
FTQ Ratio 0.10 ± 0.14  0.11 ± 0.14 0.15 ± 0.15 0.14 ± 0.15 0.14 ± 0.14 0.15 ± 0.15 0.184 (0.832) 
        
Values are reported as mean ± standard deviation. F and p-values are reported for DAT by DRD2 group interactions. †p-value for 
results of χ2 test. aerror=182, berror=183, cerror=165, #df=5, $df=10 
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Table 2. Experiment 1: Demographic data by genotype groups (ages 18-25) 
  
DRD2  
C/C 
DAT 10R  
(n = 30) 
 
DRD2  
C/T 
DAT 10R  
(n = 45) 
 
DRD2  
T/T 
DAT 10R  
(n = 26) 
 
DRD2 
C/C 
DAT 9R 
(n = 25) 
 
DRD2  
C/T 
DAT 9R 
(n = 38) 
 
DRD2  
T/T 
DAT 9R 
(n = 26) 
 
 
 
F(2, 184) (p) 
 
DDTask RT      
        
Sooner RT 1302 ± 438 1359 ± 296 1300 ± 342 1353 ± 327 1218 ± 385 1318 ± 330 1.446 (0.238) 
Larger RT 1489 ± 403 1497 ± 274 1511 ± 333 1555 ± 270 1356 ± 314 1495 ± 318 1.792 (0.170) 
WantRT 1794 ± 399 1929 ± 348 2014 ± 383 2093 ± 325 1859 ± 392 1833 ± 402 6.198 (0.002)  
DontWantRT 1934 ± 433 2128 ± 362 2156 ± 414 2309 ± 330 2030 ± 450 1937 ± 461 8.136 (<.001) 
Overall Data        
        
Control Acc. 95.7 ± 6.0 96.2 ± 4.0 96.7 ± 2.5 97.2 ± 3.0  97.5 ± 3.0 97.3 ± 1.9 0.265 (0.767) 
ICR Average 0.75 ± 0.28 0.66 ± 0.31 0.67 ± 0.26 0.67 ± 0.22 0.58 ± 0.30 0.62 ± 0.37 0.005 (0.946) 
ICRDelayAmt        
        
Intercept 0.90 ± 0.32 0.88 ± 0.35 0.95 ± 0.36 0.96 ± 0.21 0.83 ± 0.38 0.76 ± 0.42 1.779 (0.172) 
AUC 66.8 ± 27.9 56.1 ± 30.9 52.3 ± 26.6 52.6 ± 25.6 46.2 ± 29.6 54.3 ± 35.4 1.068 (0.346) 
        
        
Values are reported as mean ± standard deviation. F and p-values are reported for DAT by DRD2 group interactions. 
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Table 3. Experiment 2 Demographic data by Task Group 
  
Standard, 
Standard 
(n = 48) 
 
Standard, 
10x 
 (n = 48) 
 
Standard, 
100x 
(n = 48) 
 
 
F(2, 141) (p) 
 
Demographics     
Age (yrs) 21.4 ± 1.7 21.5 ± 2.1 21.2 ± 1.8 0.377 (0.687) 
Edu (yrs) 15.2 ± 1.5 15.2 ± 1.5 15.0 ± 1.6 0.290 (0.749)
a
 
Subject SES 43.0 ± 3.6 43.6 ± 4.6 43.0 ± 2.8 0.222 (0.801)
b
 
Sex (% female) 50.0 50.0 50.0 (1.000)
†# 
Ethnicity (% white) 76.6 66.7 81.3 (0.226)
†# 
Psychometrics      
AUDIT 8.52 ± 5.30 7.94 ± 5.53 8.38 ± 5.48 0.150 (0.861) 
Consump. 5.40 ± 2.63 4.56 ± 2.35 5.02 ± 2.42 1.387 (0.253)
a 
Dependence 0.94 ± 1.11 0.88 ± 1.08 0.88 ± 1.27 0.044 (0.957)
a 
Harm 2.28 ± 2.50 2.48 ± 2.92 2.48 ± 2.67 0.089 (0.915)
a 
BIS 62.2 ± 10.0  59.9 ± 10.8 58.5 ± 9.6 1.659 (0.194) 
BIS Attention 16.3 ± 3.6 15.9 ± 3.7 15.8 ± 3.6 0.213 (0.809) 
BIS Motor 22.3 ± 4.3 21.5 ± 4.2 21.8 ± 3.9 0.395 (0.675) 
BIS Planning 23.5 ± 4.8 22.3 ± 4.8  20.9 ± 4.6 3.519 (0.032) 
DAST 1.92 ± 2.05 2.17 ± 2.60 2.44 ± 2.54 0.478 (0.621)
c 
DUSI 0.25 ± 0.19 0.27 ± 0.18 0.26 ± 0.20 0.080 (0.923) 
FTPI Mean 8.41 ± 6.31 5.74 ± 4.92 8.05 ± 5.53 3.192 (0.044) 
RAPI 8.54 ± 8.04 7.38 ± 7.17 8.27 ± 8.44 0.265 (0.767)
c 
FTQ Ratio 0.11 ± 0.14 0.13 ± 0.15 0.14 ± 0.14 0.789 (0.456) 
     
Values are reported as mean ± standard deviation. F and p-values are reported for DAT by DRD2 group interactions. 
†
p-value for results of χ2 test. aerror=140, berror=72, cerror=130, #df=2 
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Figure 1. DAT and DRD2 genotype interact to affect ICR by delayed amount slope. A between 
subjects 2 by 3 ANOVA revealed a significant interaction effect of DAT and DRD2 on ICR by 
delayed amount slope (F(2, 179)=10.340, p<.001). Post-hoc independent samples t-tests revealed 
significant (p<0.05) ICR delayed amount slope differences (as indicated, *) between several of 
the genotype groups. (9R = DAT 9R VNTR carrier; 10R/10R = DAT 10R VNTR homozygote; 
TT = DRD2 C957T homozygote; CT = DRD2 C957T heterozygote; CC = DRD2 957C 
homozygote) 
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Figure 2. DAT and DRD2 interact to affect differences in subjective versus objective reaction 
times. Figure 2A. A between subjects 2 by 3 ANOVA revealed a significant interaction effect of 
DAT and DRD2 on reaction time difference, calculated as WANT RT – CONTROL RT (F(2, 
179)=5.813, p=0.004). Post-hoc independent samples t-tests revealed significant (p<0.05) 
differences in this reaction time measure (as indicated, *) between several of the genotype 
groups. RT, reaction time. Figure 2B. DAT and DRD2 interact to affect differences in DON’T 
WANT versus objective reaction times. A between subjects 2 by 3 ANOVA revealed a significant 
interaction effect of DAT and DRD2 on reaction time difference, calculated as DON’T WANT 
RT – CONTROL RT (F(2, 179)=6.957, p<.001). Post-hoc independent samples t-tests revealed 
significant (p<0.05). differences in this reaction time measure (as indicated, *) between several 
of the genotype groups. RT, reaction time. 
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Figure 3. DAT and DRD2 genotype interact to affect between task change in ICR when reward 
values increased to 100x. A between subjects 2 by 3 ANOVA revealed a significant interaction 
effect of DAT and DRD2 on differences in ICR change (F(2, 41)=3.911, p=0.028). Differences in 
ICR change were calculated by subtracting ICR from the 100x delay discounting task from ICR 
from the standard delay discounting task. Post-hoc independent samples t-tests revealed 
significant (p<0.05) differences in this ICR change measure (as indicated, *), between the DAT 
9R DRD2 TT and DAT 9R DRD2 CC group and between the DAT 10R DRD2 TT group and 
DAT 10R DRD2 C carriers.  
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